Highlights
C&EN: A shocking way to produce hydrogen from plastic waste
21 September 2023Flash Joule heating converts polymers into low-cost hydrogen and graphene.
C&EN: Catalyst persuades alcohols to offer a helping hand for C-H activation
11 September 2023Tailored ligand on palladium catalyst uses hydrogen bonding to orchestrate reaction.
Nature Biotechnology: ‘Clicked’ drugs: researchers prove the remarkable chemistry in humans
05 July 2023Bioorthogonal click chemistry is being used in patients to help target cancer medicines and diagnostic imaging agents.
C&EN: Medicinal chemistry methods miniaturized for high-throughput experimentation
03 July 2023Researchers redesign 4 workhorse reactions to run in microliter droplets.
C&EN: Diberyllocene is a Be–Be king
16 June 2023First solid compound to contain a beryllium-beryllium bond could unlock unusual chemistry.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Author Archives: benbaxter
The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The FDA has finally indicated it will approve the first biosimilar drug for the United States, years after Europe.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
